{
    "code": "02024594",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024594",
    "time": "2017-02-24 03:14:28",
    "許可證字號": "衛署藥輸字第024594號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/01\/12",
    "發證日期": "96\/01\/12",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202459402",
    "中文品名": "紓癌特膠囊25毫克",
    "英文品名": "Sutent Capsules 25mg",
    "適應症": "SUTENT適用於（1）imatinib mesylate治療期間出現疾病惡化或對該藥出現不能忍受之腸胃道間質腫瘤；（2）治療晚期或轉移性腎細胞癌（病理上為亮細胞癌（clear cell carcinoma））；（3）進展性，無法切除或轉移性分化良好之胰臟神經內分泌腫瘤的成人病患。",
    "劑型": "130膠囊劑",
    "包裝": "4-1000粒塑膠瓶裝 鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "SUNITINIBMALATE"
    ],
    "限制項目": "02輸　入 54依本署89、12、12衛署藥字第0890035812號公告事項九得免除國內進行臨床試驗之特殊醫療需要之新藥",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F250458000  PFIZER ITALIA S.R.L.",
        "製造廠廠址": "LOCALITA MARINO DEL TRONTO, 63100 ASCOLI PICENO, ITALY",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000131",
            "成分名稱": "SUNITINIB MALATE",
            "含量描述": "",
            "含量": "33.4000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020245940001-105-12-09.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024594&Seq=002&Type=9"
        },
        {
            "title": "Sutent 25mg_外盒包裝核定本-104-09-24(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024594&Seq=012&Type=8"
        }
    ]
}